VAXCYTE INC (PCVX) Fundamental Analysis & Valuation

NASDAQ:PCVX • US92243G1085

Current stock price

57.24 USD
-0.08 (-0.14%)
At close:
57.24 USD
0 (0%)
After Hours:

This PCVX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. PCVX Profitability Analysis

1.1 Basic Checks

  • In the past year PCVX has reported negative net income.
  • PCVX had a negative operating cash flow in the past year.
  • In the past 5 years PCVX always reported negative net income.
  • PCVX had a negative operating cash flow in each of the past 5 years.
PCVX Yearly Net Income VS EBIT VS OCF VS FCFPCVX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 -200M -400M -600M -800M

1.2 Ratios

  • PCVX has a Return On Assets of -25.53%. This is in the better half of the industry: PCVX outperforms 70.29% of its industry peers.
  • PCVX has a Return On Equity of -28.55%. This is in the better half of the industry: PCVX outperforms 76.70% of its industry peers.
Industry RankSector Rank
ROA -25.53%
ROE -28.55%
ROIC N/A
ROA(3y)-22.44%
ROA(5y)-24.08%
ROE(3y)-25%
ROE(5y)-26.74%
ROIC(3y)N/A
ROIC(5y)N/A
PCVX Yearly ROA, ROE, ROICPCVX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 -20 -40 -60 -80

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for PCVX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PCVX Yearly Profit, Operating, Gross MarginsPCVX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. PCVX Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for PCVX has been increased compared to 1 year ago.
  • The number of shares outstanding for PCVX has been increased compared to 5 years ago.
  • There is no outstanding debt for PCVX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
PCVX Yearly Shares OutstandingPCVX Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
PCVX Yearly Total Debt VS Total AssetsPCVX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • PCVX has an Altman-Z score of 14.15. This indicates that PCVX is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 14.15, PCVX belongs to the top of the industry, outperforming 85.63% of the companies in the same industry.
  • There is no outstanding debt for PCVX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 14.15
ROIC/WACCN/A
WACCN/A
PCVX Yearly LT Debt VS Equity VS FCFPCVX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

2.3 Liquidity

  • A Current Ratio of 7.91 indicates that PCVX has no problem at all paying its short term obligations.
  • PCVX's Current ratio of 7.91 is fine compared to the rest of the industry. PCVX outperforms 71.07% of its industry peers.
  • A Quick Ratio of 7.91 indicates that PCVX has no problem at all paying its short term obligations.
  • With a decent Quick ratio value of 7.91, PCVX is doing good in the industry, outperforming 71.46% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 7.91
Quick Ratio 7.91
PCVX Yearly Current Assets VS Current LiabilitesPCVX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. PCVX Growth Analysis

3.1 Past

  • PCVX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -48.13%.
EPS 1Y (TTM)-48.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-77.51%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, PCVX will show a very strong growth in Earnings Per Share. The EPS will grow by 23.46% on average per year.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-29.7%
EPS Next 2Y-9.84%
EPS Next 3Y-0.16%
EPS Next 5Y23.46%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PCVX Yearly Revenue VS EstimatesPCVX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2028 2029 2030 2031 2032 2033 1B 2B 3B 4B 5B
PCVX Yearly EPS VS EstimatesPCVX Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 5 -5 10

More info and screens

Find the best growth stocksShow best growing peers

0

4. PCVX Valuation Analysis

4.1 Price/Earnings Ratio

  • PCVX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year PCVX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PCVX Price Earnings VS Forward Price EarningsPCVX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PCVX Per share dataPCVX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-9.84%
EPS Next 3Y-0.16%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PCVX Dividend Analysis

5.1 Amount

  • PCVX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PCVX Fundamentals: All Metrics, Ratios and Statistics

VAXCYTE INC

NASDAQ:PCVX (4/30/2026, 8:11:08 PM)

After market: 57.24 0 (0%)

57.24

-0.08 (-0.14%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Industry Strength55.9
Industry Growth13.04
Earnings (Last)02-24
Earnings (Next)05-11
Inst Owners104.38%
Inst Owner Change0.31%
Ins Owners0.6%
Ins Owner Change4.03%
Market Cap8.24B
Revenue(TTM)N/A
Net Income(TTM)-766.63M
Analysts85.88
Price Target108.69 (89.88%)
Short Float %10.04%
Short Ratio11.43
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-18.49%
Min EPS beat(2)-20.53%
Max EPS beat(2)-16.44%
EPS beat(4)1
Avg EPS beat(4)-9.08%
Min EPS beat(4)-20.53%
Max EPS beat(4)2.74%
EPS beat(8)4
Avg EPS beat(8)3.01%
EPS beat(12)6
Avg EPS beat(12)-2.01%
EPS beat(16)6
Avg EPS beat(16)-3.79%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)6.32%
PT rev (3m)6.32%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-15.53%
EPS NY rev (1m)-3.32%
EPS NY rev (3m)-16.62%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)-100%
Revenue NY rev (1m)N/A
Revenue NY rev (3m)-100%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 3.07
P/tB 3.07
EV/EBITDA N/A
EPS(TTM)-5.62
EYN/A
EPS(NY)-7.29
Fwd EYN/A
FCF(TTM)-4.95
FCFYN/A
OCF(TTM)-4.56
OCFYN/A
SpS0
BVpS18.66
TBVpS18.66
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -25.53%
ROE -28.55%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-22.44%
ROA(5y)-24.08%
ROE(3y)-25%
ROE(5y)-26.74%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 347.48%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.91
Quick Ratio 7.91
Altman-Z 14.15
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)1399.92%
Cap/Depr(5y)958.19%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-48.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-77.51%
EPS Next Y-29.7%
EPS Next 2Y-9.84%
EPS Next 3Y-0.16%
EPS Next 5Y23.46%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-62.31%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-27.1%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-24.62%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-44.84%
OCF growth 3YN/A
OCF growth 5YN/A

VAXCYTE INC / PCVX Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for VAXCYTE INC?

ChartMill assigns a fundamental rating of 3 / 10 to PCVX.


What is the valuation status for PCVX stock?

ChartMill assigns a valuation rating of 0 / 10 to VAXCYTE INC (PCVX). This can be considered as Overvalued.


What is the profitability of PCVX stock?

VAXCYTE INC (PCVX) has a profitability rating of 1 / 10.